Baxter International dividend – Baxter International Declares Quarterly Dividend of $0.29/Share, Yielding 2.91%

Trending News 🌥️

Baxter International dividend – Baxter International ($NYSE:BAX) Inc. is a major healthcare company focused on solutions and treatments for patients around the world. Baxter International Inc. recently announced their quarterly dividend of $0.29 per share, consistent with the previous payout. The dividend will be payable on April 3rd to shareholders of record on February 24th, with an ex-dividend date of February 23rd. This forward yield is 2.91%.

For more detailed information regarding this dividend, investors may visit Seeking Alpha’s Baxter International Inc. Dividend Scorecard, Yield Chart, and Dividend Growth. The company is focusing on providing innovative products and services to increase patient access to quality healthcare, as well as improving their own efficiency and cost structure. To keep up with the rapidly changing healthcare industry, Baxter is making investments in product development, strategic acquisitions, and increased focus on customers’ needs. This approach has enabled Baxter to remain a leader in their field and they are well-positioned to continue to deliver value to their shareholders through this dividend payment and future ones.

Dividends – Baxter International dividend

Baxter International, a leading provider of medical products and services, has recently announced a quarterly dividend of $0.29 per share, yielding 2.91%. This marks an increase compared to the last three years of BAXTER INTERNATIONAL’s annual dividend per share, which was $1.15, $1.15 and $1.15 USD respectively. The company expects their dividend yields from 2022 to 2022 to be 1.67%, 1.67%, and 1.67%, with an average dividend yield of 1.67%. This marks an increase in the dividend yield for shareholders of Baxter International, as the company seeks to reward them for their loyalty and continued support. The quarterly dividend marks a strong commitment by Baxter International to its shareholders, as it provides shareholders with a steady income stream while building long-term wealth.

The dividend amount is also attractive to investors, as it offers a relatively high yield while still allowing investors to diversify their portfolios and reduce risk. Overall, Baxter International’s decision to declare a quarterly dividend of $0.29 per share yields 2.91% is positive news for its stakeholders. It is a sign of the company’s strong commitment to rewarding its shareholders and building long-term wealth for them. It is also an attractive option for investors who are looking for a way to diversify their portfolios and reduce risk.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Baxter International. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Baxter International. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Baxter International. More…

Key Ratios Snapshot

Some of the financial key ratios for Baxter International are shown below. More…

Share Price

On Tuesday, Baxter International declared a quarterly dividend of $0.29/share, yielding 2.91%. This reflects the company’s commitment to returning value to shareholders. This reflects the company’s commitment to increasing shareholder value over time as well as its consistent financial performance. Investors should consider Baxter International for their dividend portfolio as it is a reliable and stable company with a strong track record of paying dividends.

In addition, the current dividend yield is above the healthcare sector average and the payout ratio is in line with the industry standard. Finally, Baxter International provides investors with the added benefit of being a healthcare-focused company, benefiting from favorable demographic trends such as aging populations in many developed markets. Live Quote…

Analysis – Baxter International Intrinsic Value Calculator

GoodWhale recently conducted an analysis of the wellbeing of BAXTER INTERNATIONAL, a publicly traded company. According to their proprietary Valuation Line, the fair value of BAXTER INTERNATIONAL’s stock is around $90.3. However, currently its stock is traded at $39.9, signifying that it is undervalued by 55.8%. Given the significantly lower current price compared to the fair value, investors may have the opportunity to buy BAXTER INTERNATIONAL stock at an attractive price. Moreover, analysts expect the share price to eventually reach its true value as the company continues to perform well. BAXTER INTERNATIONAL has been able to maintain sustainable operations and its financials are in good shape. Their earnings are expected to be stable during the fiscal year and they have been able to reduce their debt levels significantly. This strong financial performance combined with their resilient business model has allowed them to weather turbulent market conditions. In conclusion, GoodWhale’s analysis of BAXTER INTERNATIONAL’s wellbeing reveals that its current valuation presents an attractive opportunity for investors. As long as the company continues to perform well, its stock price should eventually reach its fair value. More…

Peers

Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.

– Utah Medical Products Inc ($NASDAQ:UTMD)

The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.

– Clarity Medical Group Holding Ltd ($SEHK:01406)

According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.

– Merit Medical Systems Inc ($NASDAQ:MMSI)

Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.

Summary

Baxter International has declared a quarterly dividend of $0.29 per share, yielding 2.91%. This is an attractive dividend yield for investors seeking income from the stock market. The company has a strong track record of increasing its dividend payments year over year, and has a solid balance sheet that suggests it is well-positioned to continue to do so.

Furthermore, the company is likely to benefit from the ongoing equipment modernization in healthcare and other industries, which should drive future revenue and earnings growth. Investors seeking long-term value should consider investing in Baxter International as it offers a secure and stable dividend yield with potential upside potential in the stock price.